Edwards Lifesciences (EW) Non-Current Deferred Tax Liability (2009 - 2010)
Edwards Lifesciences (EW) posted Non-Current Deferred Tax Liability of -$21.9 million for Q4 2010, down 16.49% on a QoQ basis from -$18.8 million in Q4 2009, and down 16.49% year-over-year from -$26.2 million in Q4 2009.
Powered by 
Analysis
Edwards Lifesciences (EW) Non-Current Deferred Tax Liability (2009 - 2010) Analysis & Trends
Edwards Lifesciences has reported Non-Current Deferred Tax Liability for 2 years, with the latest figure at -$21.9 million in Q4 2010.
- On a quarterly basis, Non-Current Deferred Tax Liability fell 16.49% year-over-year to -$21.9 million in Q4 2010; TTM through Dec 2010 was -$21.9 million, a 16.49% decrease from a year earlier, with the FY2010 full-year figure at -$21.9 million, down 16.49% from the prior year.
- Non-Current Deferred Tax Liability was -$21.9 million for Q4 2010 at Edwards Lifesciences, down from -$18.8 million in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was -$18.8 million in Q4 2009, with the low at -$21.9 million in Q4 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.63 Bn | 178.03 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.13 Bn | 118.91 Bn | 1.96 Bn |
| 3 | Medtronic | 118.51 Bn | 109.69 Bn | 6.34 Bn |
| 4 | Stryker | 106.53 Bn | 103.06 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.52 Bn | 65.98 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.57 Bn | 45.32 Bn | 1.35 Bn |
| 7 | Alcon | 34.00 Bn | 32.55 Bn | 1.68 Bn |
| 8 | Dexcom | 32.03 Bn | 30.08 Bn | 830.00 Mn |
| 9 | Steris | 21.12 Bn | 20.64 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 18.27 Bn | 17.86 Bn | 1.54 Bn |